Geneva, Aug. 31 -- International Clinical Trials Registry received information related to the study (NCT07778862) titled 'A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gynecological Tumors and Other Solid Tumors' on Aug. 18.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Condition:
Gynecological Tumors
Solid Tumors
Intervention:
Drug: SI-B036
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: September 2026
Target Sample Size: 30
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/stu...